Wednesday, November 4, 2009

Novo Nordisk re-launches hemophilia campaign

Pin It Now!

Evelyn Lee of NJBiz.com reports that New Jersey-based pharmaceutical company, Novo Nordisk has relaunched it's hemophilia campaign. Its “changing possibilities in hemophilia” campaign with a re-branded Web site and a new community on the social networking site Facebook. The new online resources are intended to reach the hemophilia inhibitor community, which represents just 800 to 900 Americans, according to the health care company, whose U.S. headquarters are based in Princeton.

Do you think that Novo Nordisk's relaunch will be a success?
Post a Comment